Results 161 to 170 of about 1,249,380 (278)

Illegitimate tasks and quiet quitting: a moderated mediation model based on the strength model of self-control. [PDF]

Front Psychol
Liu C, Chi Z, Sui Y.
europepmc   +1 more source

VSED Should Not Be a Pathway to MAiD (Though Both Are Ethically Permissible)

Bioethics, EarlyView.
ABSTRACT Recent changes in aid in dying laws have led some to argue for a pathway from Voluntarily Stopping Eating and Drinking (VSED) to Medical Aid in Dying (MAiD). Proponents point to the Sontag case as demonstrating the efficacy of the practice. This article first provides an overview of the development of the practice of VSED and MAiD and provides
D. B. Davison
wiley   +1 more source

A Survey of Current Operations-Ready Thermospheric Density Models for Drag Modeling in LEO Operations. [PDF]

J Astronaut Sci
Mutschler S, Pilinski M, Bruinsma S, Sutton E, Tobiska WK, Knipp D, Fang TW, Casali S, Mallik V, DiLorenzo B, Siemes C.   +10 more
europepmc   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

British Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes, Florian Buehning, Tobias Lerchner, Julia Vogel, Raluca I. Mincu, Matthias Totzeck, Tienush Rassaf, Lars Michel   +7 more
wiley   +1 more source

Development and validation of the quiet quitting behavior scale: a mixed-methods study with primary healthcare workers in China. [PDF]

Front Public Health
Li QL, Sun T, Zhang X.
europepmc   +1 more source

The nitty‐gritty of vascular permeability in cancer: targeting blood endothelium to control metastases

British Journal of Pharmacology, EarlyView.
Blood vascular permeability is a hallmark of cancer and acts as an active driver of metastatic dissemination. Metastasis accounts for the vast majority of cancer deaths, yet most work has focussed on tumour‐intrinsic traits and angiogenesis, while the specific contribution of endothelial barrier regulation to intravasation and extravasation remains ...
Pierre Boucher, Mérone Da Costa Oliveira, Adrien Levesque, Alexandre Rutault, Patrick Savoyaud, Nicolas Bréchot, Stéphane Germain   +6 more
wiley   +1 more source

CD93—An emerging vascular target in cancer therapy

British Journal of Pharmacology, EarlyView.
Abstract CD93 is a single‐pass transmembrane glycoprotein that belongs to the C‐type lectin domain group XIV family of proteins. Although it is known to be expressed in other cell types, namely, in some subsets of immune cells, CD93 is primarily expressed on endothelial cells, where it acts as a crucial regulator of angiogenesis.
Beatriz de Alves Pereira, Stefano Barbera, Roberta Lugano, Anna Dimberg   +3 more
wiley   +1 more source

Correction: Bavachin ameliorates cisplatin-induced nephrotoxicity by enhancing mitochondrial β-oxidation and lipid metabolism through MFN2. [PDF]

Mol Med
Luo S, Yang M, Jiang N, Li C, Liu Y, Sun L.   +5 more
europepmc   +1 more source

Long non‐coding RNAs at the crossroads of inflammation, cancer and angiogenesis: Molecular mechanisms and their potential as therapeutic targets

British Journal of Pharmacology, EarlyView.
Long non‐coding RNAs (lncRNAs), a broad class of non‐protein‐coding RNAs, are characterized as new regulators of gene expression at the epigenetic, transcriptional, and post‐transcriptional level. Thus, lncRNAs are involved in the regulation of physiological processes and the development of human diseases and cancer by modulating proinflammatory ...
Charlie Leboff, Pamela Calle‐Mendoza, Maria Hatziapostolou, Christos Polytarchou   +3 more
wiley   +1 more source

Investigating the Relationship Between Physical Properties and Spatial Irregularities at Coronal Hole Boundaries. [PDF]

Sol Phys
Ngampoopun N, Long DM, Green LM, Yardley SL, James AW, Mason EI, Heinemann SG, Uritsky VM.   +7 more
europepmc   +1 more source